nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease
|
Guilcher, Gregory M.T. |
|
2018 |
55 |
2 |
p. 87-93 |
artikel |
2 |
Fetal Hemoglobin Induction by Epigenetic Drugs
|
Lavelle, Donald |
|
2018 |
55 |
2 |
p. 60-67 |
artikel |
3 |
Genetic therapies for sickle cell disease
|
Esrick, Erica B. |
|
2018 |
55 |
2 |
p. 76-86 |
artikel |
4 |
Novel Sickle Cell Disease Therapies: Targeting Pathways Downstream of Sickling
|
Morrone, Kerry |
|
2018 |
55 |
2 |
p. 68-75 |
artikel |
5 |
outside front cover, PMS 8883 metallic AND 4/C
|
|
|
2018 |
55 |
2 |
p. OFC |
artikel |
6 |
Sickle cell disease: Translating clinical care to low-resource countries through international research collaborations
|
Smart, Luke R. |
|
2018 |
55 |
2 |
p. 102-112 |
artikel |
7 |
Sickle cell disease—Unanswered questions and future directions in therapy
|
Thein, Swee Lay |
|
2018 |
55 |
2 |
p. 51-52 |
artikel |
8 |
Targeting HbS Polymerization
|
Ferrone, Frank A. |
|
2018 |
55 |
2 |
p. 53-59 |
artikel |
9 |
When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease
|
Joseph, Jacinth J. |
|
2018 |
55 |
2 |
p. 94-101 |
artikel |